Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia.

Authors:
Sarfraz Saleemi

Ann Thorac Med 2014 Jul;9(Suppl 1):S67-73

Department of Medicine, Division of Pulmonary Medicine, King Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.

Hereditary hemoglobin disorders affecting the globin chain synthesis namely thalassemia syndromes and sickle cell disease (SCD) are the most common genetic disorders in human. Around 7% of the world population carries genes for these disorders, mainly the Mediterranean Basin, Middle and Far East, and Sub-Saharan Africa. An estimated 30 million people worldwide are living with sickle cell disease, while 60-80 million carry beta thalassemia trait. About 400,000 children are born with severe hemoglobinopathies each year. Cardiovascular complications of hemoglobinopathies include left and right ventricular (RV) dysfunction, arrhythmias, pericarditis, myocarditis, valvular heart disease, myocardial ischemia, and notably pulmonary hypertension (PH). Because of a unique pathophysiology, pulmonary hypertension associated with hemolytic disorders was moved from WHO group I to group V PH diseases. Treatment strategies are also unique and include blood transfusion, iron chelation, hydroxyurea, and oxygen therapy. The role of PH-specific agents has not been established.

Download full-text PDF

Source
http://dx.doi.org/10.4103/1817-1737.134039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114267PMC
July 2014
76 Reads

Publication Analysis

Top Keywords

pulmonary hypertension
16
hypertension associated
8
sickle cell
8
cell disease
8
associated hemolytic
8
disease myocardial
4
group diseases
4
60-80 carry
4
diseases treatment
4
disease 60-80
4
mediterranean basin
4
carry beta
4
trait 400000
4
group group
4
thalassemia trait
4
beta thalassemia
4
living sickle
4
worldwide living
4
middle east
4
unique include
4

Similar Publications